Gene therapy of human melanoma. Immunization of patients with autologous tumor cells admixed with allogeneic melanoma cells secreting interleukin 6 and soluble interleukin 6 receptor.
Mackiewicz
A
A
Dept. of Cancer Immunology, University School of Medical Sciences at GreatPoland Cancer Center, Poznań.
Górny
A
A
Laciak
M
M
Malicki
J
J
Murawa
P
P
Nowak
J
J
Wiznerowicz
M
M
Hawley
R G
RG
Heinrich
P C
PC
Rose-John
S
S
D000818:Animals; D015703:Antigens, CD / Q000235:genetics* / Q000378:metabolism; D002985:Clinical Protocols; D015316:Genetic Therapy; D006801:Humans; D007167:Immunotherapy; D007258:Informed Consent; D015850:Interleukin-6 / Q000235:genetics* / Q000378:metabolism / Q000627:therapeutic use; D008545:Melanoma / Q000235:genetics* / Q000276:immunology / Q000378:metabolism / Q000628:therapy; D051379:Mice; D018579:Patient Selection; D018123:Receptors, Interleukin / Q000235:genetics* / Q000378:metabolism; D019947:Receptors, Interleukin-6
D015703:Antigens, CD; D015850:Interleukin-6; D018123:Receptors, Interleukin; D019947:Receptors, Interleukin-6